Results 31 to 40 of about 210,681 (329)

Very Long-Term Outcomes of Cardiac Resynchronization Therapy in Patients With Ischemic and Nonischemic Cardiomyopathy. [PDF]

JACC Adv
Gupta AR, Karikalan S, Katukuri N, Kumar A, Kowlgi GN, DeSimone CV, Del-Carpio Munoz F, Ezzeddine F, Lee JZ, Cha YM, Asirvatham S, Mulpuru S, Killu A, Madhavan M, Friedman P, Sugrue A, Tan N, Deshmukh AJ.   +17 more
europepmc   +2 more sources

Cardiac Resynchronization Therapy Upgrade [PDF]

Circulation: Arrhythmia and Electrophysiology, 2017
The implant rates of cardiac resynchronization therapy (CRT) increased rapidly through the first decade of this millennium but have plateaued more recently and may even have started to decrease in Europe and the United States.1,2 The upgrade of existing pacemakers and implantable cardioverter defibrillators (ICDs) to CRT currently accounts for a ...
Anoop K, Shetty, Christopher A, Rinaldi
openaire   +2 more sources

The response to cardiac resynchronization therapy in LMNA cardiomyopathy

European Journal of Heart Failure, 2022
Cardiac implantable electronic device (CIED) therapy is fundamental to the management of LMNA cardiomyopathy due to the high frequency of atrioventricular block and ventricular tachyarrhythmias.
K. Sidhu, A. I. Castrini, V. Parikh, N. Reza, A. Owens, Maxime Tremblay-Gravel, M. Wheeler, L. Mestroni, M. Taylor, S. Graw, M. Gigli, M. Merlo, A. Paldino, G. Sinagra, D. Judge, Hannia Ramos, Olurotimi O. Mesubi, E. Brown, S. Turnbull, S. Kumar, Darius Roy, U. Tedrow, L. Ngo, K. Haugaa, N. Lakdawala   +24 more
semanticscholar   +1 more source

Role of cardiac resynchronization therapy in the development of new-onset atrial fibrillation: A single-center prospective study. [PDF]

, 2012
Albeit several studies examined the association between cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) in heart failure (HF), results are still unclear and quite conflicting.
Cristofaro d', Gaetano Santulli, Massimo Chiariello, Salvatore d'   +3 more
core   +3 more sources

Infection and migration incidence of cardiac implantable electrical devices in Japan: Web‐based survey results

Journal of Arrhythmia, 2020
Web‐based survey was conducted for experiences of cardiac implantable electrical device (CIED) infection and migration in Japan. A total of 155 cardiologists’ answer was collected in January, 2018.
Hiroshi Nakajima, Nobuhiro Nishii
doaj   +1 more source

Cardiac-Resynchronization Therapy

New England Journal of Medicine, 2011
Systolic heart failure is a major problem for Americans today, with 550,000 new cases diagnosed per year, and ultimately contributes to 287,000 deaths annually. While pharmacologic therapy has drastically improved outcomes in patients with systolic heart failure, hospitalizations from systolic heart failure continue to increase and remain a major cost ...
Robert S, Rosenstein, David, Parra
openaire   +5 more sources

Left cardiac atrioventricular delay and inter-ventricular delay in cardiac resynchronization therapy responder and non-responder

Current Directions in Biomedical Engineering, 2016
Cardiac resynchronization therapy is an established therapy for heart failure patients. The aim of the study was to evaluate electrical left cardiac atrioventricular delay and interventricular desynchronization in sinus rhythm cardiac resynchronization ...
Heinke Matthias, Kühnert Helmut, Heinke Tobias, Tumampos Jonas, Dannberg Gudrun   +4 more
doaj   +1 more source

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care

European Journal of Heart Failure, 2020
Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart failure with reduced ejection fraction and leads to improved quality of life, reductions in heart failure hospitalization rates and all‐cause mortality. Nevertheless,
W. Mullens, A. Auricchio, Pieter Martens, K. Witte, M. Cowie, V. Delgado, K. Dickstein, C. Linde, K. Vernooy, F. Leyva, J. Bauersachs, C. Israel, L. Lund, E. Donal, G. Boriani, T. Jaarsma, A. Berruezo, V. Traykov, Z. Yousef, Z. Kalarus, J. Cosedis Nielsen, J. Steffel, P. Vardas, A. Coats, P. Seferovic, T. Edvardsen, H. Heidbuchel, F. Ruschitzka, C. Leclercq   +28 more
semanticscholar   +1 more source

Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant. [PDF]

, 2014
Aims: Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results.
Francis, DP, Hughes, AD, Jones, S, Kanagaratnam, P, Kyriacou, A, Manisty, CH, Mayet, J, Peters, NS, Sohaib, SM, Whinnett, ZI   +9 more
core   +2 more sources

Reduction in the QRS area after cardiac resynchronization therapy is associated with survival and echocardiographic response

Cardiovascular Electrophysiology, 2021
Recent studies have shown that the baseline QRS area is associated with the clinical response after cardiac resynchronization therapy (CRT). In this study, we investigated the association of QRS area reduction (∆QRS area) after CRT with the outcome.
M. Ghossein, A. V. van Stipdonk, F. Plesinger, M. Kloosterman, P. Wouters, O. Salden, M. Meine, A. Maass, F. Prinzen, K. Vernooy   +9 more
semanticscholar   +1 more source